Skip to main content

Advertisement

Log in

QSAR and CoMFA studies of biphenyl analogs of the anti-tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo [2,1-b][1,3]oxazine (PA-824)

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

With the purpose of designing new chemical entities with enhanced inhibitory potencies against Mycobacterium tuberculosis, the 3D-QSAR CoMFA study carried out on biphenyl analogs of the tuberculosis drug, (6S)-2-nitro-6-{[4-trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824), is presented here. The developed model showed a good correlative and predictive ability. The final QSAR models as well as the information gathered from 3D contour maps should be useful for the design of novel PA-824 analogs having improved anti-TB activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Cramer RD, Patterson DE, Bunce JD (1988) Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110:5959–5967. doi:10.1021/ja00226a005

    Article  PubMed  CAS  Google Scholar 

  • Denny WA, Palmer BD, Thompson AM, Sutherland HS, Blaser A, Kmentova I, Franzblau SG, Wan B, Wang Y, Ma Z (2010) Synthesis and structure-activity studies of biphenyl analogues of the tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy) benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824). J Med Chem 53:282–294. doi:10.1021/jm901207n

    Article  PubMed  Google Scholar 

  • Hadda TB, Bennani B, Kerbal A, Daoudi M, Filali Baba B, Al Houari G, Jalbout AF, Mimouni M, Benazza M, Demailly G, Akkurt M, Öztürk Yýldýrým S (2007) Combined drug design of potential Mycobacterium tuberculosis and HIV-1 inhibitors: 3′,4′-di-substituted -4′H-spiro[isothiochromene-3,5′-isoxazol]-4(1H)-one. ARKIVOC XVI:19–40

    Google Scholar 

  • Masand VH, Patil KN, Nazerruddin GM, Jawarkar RD, Bajaj SO (2010) Correlation potential of Wiener index vis-a-vis molecular refractivity: anti-malarial activity of xanthone derivatives. Org Chem Indian J 6(1):30–38

    CAS  Google Scholar 

  • Singh SK, Dessalew N, Bharatam PV (2007) 3D-QSAR CoMFA study on oxindole derivatives as cyclin dependent kinase 1 (CDK1) and cyclin dependent kinase 2 (CDK2) inhibitors. Med Chem 3:75–84

    Article  PubMed  CAS  Google Scholar 

  • Zhang N, Zhong R (2010) Docking and 3D-QSAR studies of 7-hydroxycoumarin derivatives as CK2 inhibitors. Eur J Med Chem 45:292–297. doi:10.1016/j.ejmech.2009.10.011

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

Authors are thankful to Dr. F.C. Raghuwanshi, Principal, Vidya Bharati Mahavidyalaya, Amravati for providing necessary help and support

Conflict of interest

Authors disclose no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vijay H. Masand.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Masand, V.H., Jawarkar, R.D., Mahajan, D.T. et al. QSAR and CoMFA studies of biphenyl analogs of the anti-tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo [2,1-b][1,3]oxazine (PA-824). Med Chem Res 21, 2624–2629 (2012). https://doi.org/10.1007/s00044-011-9787-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-011-9787-x

Keywords

Navigation